Gene · 9235
Papers3,054
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,054
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-nucleotide polymorphisms in genes associated with the vitamin D pathway related to clinical and therapeutic outcomes of American tegumentary leishmaniasis. | Front Cell Infect Microbiol | 2024 | 39844838 | PubTator, text mining | PubMed |
| Interleukin-32 positive immune and resident cells in kidney samples from lupus patients: a pilot study. | Front Immunol | 2024 | 39835128 | PubTator, text mining | PubMed |
| scACT: Accurate Cross-modality Translation via Cycle-consistent Training from Unpaired Single-cell Data. | Proc ACM Int Conf Inf Knowl Manag | 2024 | 39628660 | PubTator, text mining | PubMed |
| Regulation of Inflammation, Lipid Metabolism, and Liver Fibrosis by Core Genes of M1 Macrophages in NASH. | J Inflamm Res | 2024 | 39624402 | PubTator, text mining | PubMed |
| Identification of the key targets for sepsis-associated acute kidney injury by RNA sequencing combined with bioinformatics methods. | BMC Immunol | 2024 | 39616313 | PubTator, text mining | PubMed |
| Immune microenvironment of Epstein-Barr virus (EBV)-negative compared to EBV-associated gastric cancers: implications for immunotherapy. | J Immunother Cancer | 2024 | 39572160 | PubTator, text mining | PubMed |
| IL-32γ Induced Autophagy Through Suppression of MET and mTOR Pathways in Liver Tumor Growth Inhibition. | Int J Mol Sci | 2024 | 39519229 | PubTator, text mining | PubMed |
| A novel genetic association of IL32 with tuberculosis. | Cytokine | 2024 | 39442340 | PubTator, text mining | PubMed |
| Pericytes Modulate Third-Generation Tyrosine Kinase Inhibitor Sensitivity in EGFR-Mutated Lung Cancer Cells Through IL32-β5-Integrin Paracrine Signaling. | Adv Sci (Weinh) | 2024 | 39435643 | PubTator, text mining | PubMed |
| Transcriptome-wide RNA m6A methylation profiles in an endemic osteoarthropathy, Kashin-Beck disease. | J Cell Mol Med | 2024 | 39428571 | PubTator, text mining | PubMed |
| Characteristics of PD-1+CD4+ T cells in peripheral blood and synovium of rheumatoid arthritis patients. | Clin Transl Immunology | 2024 | 39345753 | PubTator, text mining | PubMed |
| Enhanced Association of Novel Cardiovascular Biomarkers Fetuin-A and Catestatin with Serological and Inflammatory Markers in Rheumatoid Arthritis Patients. | Int J Mol Sci | 2024 | 39337398 | PubTator, text mining | PubMed |
| Time series analysis combined with transcriptome sequencing to explore characteristic genes and potential molecular mechanisms associated with ultrasound-guided microwave ablation of glioma. | Int J Hyperthermia | 2024 | 39317933 | PubTator, text mining | PubMed |
| Corrigendum to "IL-32 aggravates metabolic disturbance in human nucleus pulposus cells by activating FAT4-mediated Hippo/YAP signaling" [Int. Immunopharmacol. 141 (2024) 112966]. | Int Immunopharmacol | 2024 | 39294029 | PubTator, text mining | PubMed |
| Research on key pathogenesis and potential intervention targets of idiopathic renal calculi composed of calcium oxalate (CaOx) based on bioinformatics. | Transl Androl Urol | 2024 | 39280684 | PubTator, text mining | PubMed |
| Potential drug targets for osteoporosis identified: A Mendelian randomization study. | Heliyon | 2024 | 39253131 | PubTator, text mining | PubMed |
| Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapy. | Cancer Immunol Immunother | 2024 | 39235457 | PubTator, text mining | PubMed |
| Elucidating the role of tumor-associated ALOX5+ mast cells with transformative function in cervical cancer progression via single-cell RNA sequencing. | Front Immunol | 2024 | 39224598 | PubTator, text mining | PubMed |
| Association Between Serum Interleukin-32 Level and Disease Status in Cases with Neuromyelitis Optica Spectrum Disorders. | J Inflamm Res | 2024 | 39219816 | PubTator, text mining | PubMed |
| IL-2 and TCR stimulation induce expression and secretion of IL-32β by human T cells. | Front Immunol | 2024 | 39211051 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9235/papers?page=10